Conventional plasma isoenzyme and enzyme values usually are normal during the first few hours of acute myocardial infarction. Thus definitive diagnosis may be delayed. We have shown recently that infarction in dogs can be detected within 1 hr after coronary occlusion by analysis of relative activities of MM creatine kinase (CK) isoforms in plasma. Isoforms of MM CK evolve through posttranslational modifications in plasma of the form released from tissue (MMA) to MMB and MMc. In this study we quantified changes in isoform profiles in the first available plasma samples from patients with evolving myocardial infarction, from patients with angina, and from normal subjects. In the 26 control subjects, the ratio of MMA to MMC was 1.09 0.4 (SE) (range 0.31 to 3.1; upper limit of normal [defined as the mean plus 2 SD] 2.5). In the seven control patients with coronary artery disease, the ratio of MM to MM was 1.3 0.3 with a range of 0.5 to 2.5. In contrast, among the 28 patients A c with acute myocardial infarction, the ratio of MMA to MMC in the first available plasma sample averaged 14.6 + 4.5 (p < .01 compared with both control groups). First available samples were obtained 3.9 -+-0.4 hr after the onset of pain. In 24 of 28 patients (86%) the ratio of MMA to MMC was greater than 2.5. Thus unequivocal changes in isoform profiles were evident in samples in which total and MB CK were within normal limits (79.7 6.2 IU/liter for total CK and 4.4 0.4 IU/liter for MB CK in patients with infarction compared with 90 ± 6.5 and 68 11 IU/liter for total CK and 4.5 ± 0.4 and 4 ± 0.8 IU/liter for MB CK in normal control subjects and patients with angina, respectively). Accordingly, diagnostic changes in CK isoform profiles occur early after the onset of acute myocardial infarction.
ACUTE MYOCARDIAL INFARCTION often cannot be detected definitively for several hours by assay of conventional plasma enzymes or isoenzymes. Thus patients with suspected infarction often must be admitted to intensive care facilities before unequivocal laboratory results become available. We have shown previously that infarction can be detected definitively as early as 1 hr after coronary occlusion in dogs by analysis of changes in creatine kinase (CK) subforms of the MM isoenzyme (isoforms) reflecting posttrans-lational modification. ' MM CK in myocardium (MMA) is a homodimer of two M chains,2 each with a terminal lysine. After release of MMA into plasma, the terminal lysine group from one chain is removed rapidly, yielding MMB, an isoform with a terminal lysine on one chain.
Subsequently, cleavage of the terminal lysine from the other chain yields a third isoform, MMc . 3 The isoforms can be separated by several physical procedures. '-7 When heart muscle undergoes irreversible injury, it liberates MMA,8 9 the tissue MM CK isoform, into the circulation, along with other macromolecules such as MB CK, transaminase, and myoglobin. Judging from results in experimental animals, once MMA is exposed to plasma it undergoes sequential conversion to MMB and MM.2, 10 The rates of conversion are consistent when physiologic conditions do not change but may vary under conditions in which amounts or activities of converting factors in plasma vary." In dogs, the relative activities of isoforms in plasma after myocardial infarction change predictably with time. Thus, in dogs with coronary occlusion, we observed consistent changes in relative proportions of isoforms in plasma before total CK or MB CK activity exceeded the normal. Furthermore, isoform changes reflected infarction within 1 hr after its onset.' To determine whether comparably prompt and potentially diagnostic changes in plasma isoform profiles occur in patients, we implemented the present study. Plasma isoforms were assayed with a nondenaturing procedure developed to permit quantitative assessment of multiple samples simultaneously. 12 First available blood samples from patients with suspected acute myocardial infarction were assayed to determine whether diagnostic changes in isoform profiles were evident very early after the onset of symptoms.
Methods
Subjects. Twenty-eight patients admitted to the Coronary Care Unit at Barnes Hospital with a time of onset of symptoms of acute myocardial infarction that could be established definitively by history, with total and MB CK within the normal range in the initially available blood sample, and with subsequent serial MB and total CK values confirmatory of acute infarction were included. Twenty-six normal subjects, 17 men and nine women of 21 to 73 years of age, without history, physical, or laboratory criteria of ischemic heart disease and without trauma to skeletal muscle within 24 hr before study served as normal controls. Seven patients with coronary artery disease proved by cardiac catheterization who presented with chest pain typical of ischemia and in whom infarction was excluded by persistently normal values for MB CK served as a second control group.
This group comprised six men and one woman who ranged in age from 41 to 68 years. Samples analyzed from this group were those available initially, i.e., the first available samples from each patient, corresponding to those analyzed in patients with infarction.
Biochemical procedures Determination of total CK activity. Total CK activity was determined spectrophotometrically in a GEMENI miniature centrifugal analyser at 370 with a coupled enzyme system'3 and expressed as international units per liter. Assays were performed with and without creatine phosphate to exclude apparent CK activity attributable to adenylate kinase. Normal values, based on results in 102 normal control subjects, were defined as 82 + 5 IU/liter (SE) with an upper limit (mean + 2 SD) of 184 IU/liter. MB CK activity was assayed with a modified microbatch filtration procedure as previously described. 14 In brief, MB and BB CK were first adsorbed to porous glass beads. MM CK was removed by filtration. MB and BB CK were desorbed by ion exchange. The combined MB and BB CK fraction was assayed spectrophotometrically at 37°for CK activity (IU/liter). Normal values, based on results for 102 normal control subjects, were defined as 4.8 + 0.4 IU/liter with an upper limit (mean + 2 SD) of 12 IU/liter. MM CK isoforms were assayed with an immunoblot procedure developed in our laboratory'2 and modified for use in patients. Plasma samples were subjected initially to ethanol precipitation to reduce the concentration of non-CK protein. Samples were then concentrated 10to 15-fold by centrifugation with Centriflo membrane cones (Amicon 25CF) at 2000 g. Isoforms were separated by electrophoresis for 6 hr at 400 V on agarose and then blotted to nitrocellulose. Blots were incubated first with anti-MM CK anti-(goat) and subsequently with 125Ilabeled antigoat immunoglobulin G (rabbit). After drying, the blots were taped to onionskin paper and exposed to x-ray film for 4 hr. Loci of radioactivity were traced onto the nitrocellulose. Radioactivity in each region identified was assayed by well counting. Serial dilutions of equal amounts of the three purified isoforms demonstrated predicted recoveries of activity within 2% (SD). Results were linear for activity between 3 and 80 mIU/isoform. Activity greater than 5% of total MM CK activity for any of the individual isoforms was detected reliably when total MM CK was 50 IU/liter or greater. Values correlated closely with those obtained by chromatofocusing, a nondenaturing procedure developed and validated previously in our laboratory but one less readily applicable to large numbers of samples (mean difference 5 + 0.9% [SE], n = 18).
Results
Total plasma CK in samples from the 26 control subjects averaged 90 6.5 (SE) IU/liter with a range of 48 to 157 IU/liter. MB CK averaged 4.5 0.4 IU/liter with a range of 4 to 9. MMA, MMB, and MMc isoforms comprised 33.5 2.3%, 29.6 + 1.4%, and 36.9 + 2.2% of total MM CK activity. The average ratio of MMA to MMC was 1.09 + 0. 14 with a range of 0.31 to 3. 1. The upper limit of normal for this ratio was considered to be 2.5 (mean + 2 SD).
In the patients with coronary artery disease and chest pain, samples were obtained a mean of 5 2 hr after the onset of chest pain. Total and MB CK in these samples averaged 68 11 and 4 ± 0.8 IU/liter, respectively. These values were not significantly different from those observed in normal control subjects.
MMA, MMB, and MMC values wete similar to those in the normal control subjects as well and comprised 43 5% 20 ± 3% and 37 + 4% of total MM CK activity. The mean MMA to MMc ratio was 1.3 ± 0.3 with a range of 0.5 to 2.5. Among the 28 patients with infarction (table 1), the mean interval from onset of pain to initial sampling was 3.9 ± 0.4 hr. In four patients samples were obtained within 2 hr. In 13 additional patients they were obtained within 4 hr. Mean total CK in initially available samples was well within the normal range, averaging 79.7 ± 6.2 IU/liter (table 2). Values ranged from 26 to 141 IU/liter. They were indistinguishable from those in the control groups (figure 1). MB CK was normal as well, averaging 4.4 + 0.4 IU/liter with a range of 1 to 1 1 and not significantly different compared with values in control subjects. In contrast, the relative activities of MMA, MMB, and MMC in the same samples were strikingly different from those in controls. MMA, MMB, and MMC comprised 68.6 ± 3%, 17.9 ± 1. 9%, and 13.5 ± 1.6% of total MM CK activities. Values for each isoform were significantly different from those in control subjects (p < .01 or less 106 CIRCULATION inherent in identifying the time of onset of infarction. Thus the time from the onset of infarction to the time of acquisition of initial samples may have been even more brief than it appeared. The early diagnostic sensitivity of the isoform ratio probably reflects the early ingress into plasma of a small amount of the tissue form of MM CK (MMA) and the relatively long half-life of MMc in the circulation.
The modest increase in MMA appears to be insufficient to elevate total CK activity. However, because plasma from normal subjects contains a large proportion of MMC and only a modest amount of total MM CK activity, MMA ingress influences the MMA to MMC ratio markedly. Although altered early after the onset of infarction, the diagnostic power of the ratio of MMA to MMC diminishes with time because release of MMA into the circulation diminishes while conversion of MMA to MMB and MMC continues.' Nevertheless, for each comparison; figure 2 ). The ratio of MMA to MMC was greater than 2.5 in the first available sample from 24 of the 28 patients ( figure 3 ) with a mean value of 14.6 ± 4.5 (p < .01 comparedwith values in both control groups) and a range from 1: 1 to 93: 1. In three of the four patients from whom samples were obtained less than 2 hr after the onset of symptoms (average interval 1.1 hr) and in an additional 11 of 13 patients from whom samples were obtained more than 2 but less than 4 hr after onset, the ratio of MMA to MMC exceeded the upper limit of normal (>2.5).
Discussion
These results indicate that changes in the relative activities of MM CK isoforms in plasma occur rapidly after the onset of myocardial infarction at a time when conventional criteria such as plasma MB CK and total CK activities are still well within the normal range.
The diagnostic sensitivity of the ratio of MMA to MMC activity in the first available sample appears to be 86%. Changes occur as early as 30 min after the onset of symptoms. These results are consistent with those we observed in experimental animals. This criterion is useful before elevation of total and MB CK. Although in many patients elevations of total and/or MB CK may occur within 4 hr, 15 in others they do not. 16 Serial rather than solitary values are advocated often for definitive diagnosis. With isoforms, however, only one very early sample is required. The large number of patients with normal total and MB CK may reflect difficulties among the eight patients studied 6 to 9 hr after the onset of symptoms, the MMA to MMc ratio in the initial sample was abnormal in 88%. Thus the ratio appears to remain abnormal throughout the interval before elevation of MB CK, which subsequently provides a reliable diagnostic criterion. 17 Accordingly, the combined use of isoform and isoenzyme assays should facilitate prompt detection of myocardial necrosis throughout the interval early after the onset of infarction, allowing for more appropriate triage for therapy (e.g., the use of thrombolytic agents) and more costeffective utilization of hospital facilities (e.g., intensive care units). The sensitivity of isoform analysis for early detection of infarction does not appear to be critically dependent on the extent of infarction. Infarcts associated with peak total plasma CK as low as l 13 IU/liter and MB CK as low as 13 IU/liter but with characteristic serial changes of both were detectable based on changes in the MMA to MMC ratio. Because MM CK is abundant in skeletal as well as cardiac muscle, the specificity of isoform abnormalities will be limited compared with the specificity of elevated MB CK as a criterion of myocardial infarction. Accordingly, patients with musculoskeletal injury were excluded from our study. In addition, we compared the patients' results with a normal range of values established from a group of normal controls to avoid the possibility of positive results in patients with unstable angina that might occur because of minute amounts of myocardial necrosis and the sensitivity of our measure. Although we have not compared the sensitivity of the MMA to MMC ratio with serial plasma values for MB CK, the fact that this ratio can be markedly abnormal while total CK remains well within the normal range makes it likely that isoform analysis will provide a more sensitive early criterion of myocardial necrosis than assay of MB CK. However, none of seven patients with proven coronary artery disease and chest pain manifested a ratio of MMA to MMc greater than 2.5: 1 in samples drawn shortly after the onset of chest pain, documenting the high specificity of this measure for muscle injury.
The present results were obtained with prototype assays of isoforms requiring prolonged incubations and processing of samples.12 They demonstrate, albeit retrospectively, the rapidity with which diagnostic changes occur. Prospective applications of isoform r I analysis for early diagnosis will require implementation of rapid assay procedures presently under development. Until recently, only semiquantitative methods have been available for isoform analysis.5-7 Chromatofocusing was developed as a nondenaturing, quantitative approach.4 However, it is not convenient for evaluation of large numbers of samples. Thus the immunoblot procedure developed and standardized with reference to chromatofocusing was employed in this study to facilitate analysis of large numbers of samples simultaneously. 12 A rapid, enzyme-linked immunosorbent assay procedure now under development in our laboratory will be standardized with respect to both. The present results indicate that characteristic and diagnostic changes in isoform patterns occur remarkably soon after the onset of acute myocardial infarction and that they are usually manifest in the first available plasma sample.
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